Report shows Hologic leading 3D tomosynthesis market

Hologic continues to lead the 3D tomosynthesis marketplace as both Siemens and GE attempt to catch up, according to a new report from research and insights firm KLAS.

The report, "Women’s Imaging 2015: Are New Technologies Delivering Promised Benefits?," shows Siemens has made progress since gaining FDA approval for 3D tomosynthesis back in April. GE, according to the report, is experiencing delays due to technical difficulties, slowing down the company’s progress.

The KLAS report also examined which companies are offering the best breast ultrasound image quality. Philips came out on top, followed by Toshiba, Siemens, and GE Healthcare. Toshiba, meanwhile, received the highest overall satisfaction score.

Companies are slow to purchase automated breast ultrasound equipment, the report added, but GE has gained market share by moving forward while some competitors wait.

KLAS research director Monique Rasband said companies are eager to show the world their advancements in imaging, especially women’s imaging.

"Patients are knowledgeable about women's imaging and are seeking out healthcare organizations that use top-performing equipment for their procedures," Rasband said in a statement. "Patient satisfaction is driving industry innovation and leading organizations to proactively inform the public now about their updated imaging technology."

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.